Brokers Issue Forecasts for TBPH FY2024 Earnings
Theravance Biopharma, Inc. (NASDAQ:TBPH – Free Report) – Equities research analysts at HC Wainwright issued their FY2024 earnings per share (EPS) estimates for Theravance Biopharma in a note issued to investors on Tuesday, February 25th. HC Wainwright analyst D. Tsao forecasts that the biopharmaceutical company will post earnings per share of ($1.01) for the year. […]
